Shares of Bausch Health, formerly Valeant, rise 3% on FDA approval of psoriasis treatment

Shares of Bausch Health, formerly Valeant, rise 3% on FDA approval of psoriasis treatment

Bausch Health, formerly known as Valeant Pharmaceuticals, said Thursday that it and its dermatology business, Ortho Dermatologics, received approval from the Food and Drug Administration for its DUOBRII lotion to treat plaque psoriasis.

jQuery(document).ready(function($) { $.post('http://www.majoronline.com/wp-admin/admin-ajax.php', {action: 'wpt_view_count', id: '252'}); });